A groundbreaking catalyst has been unveiled by scientists, enabling the direct conversion of methane into bioactive compounds ...

Despite their differences, patients go to Catalyst Life Services to address their dependence on chemicals, a disease known as ...

CPRX Q3 earnings and revenues beat estimates, driven by strong Firdapse and Agamree sales, while raising the full-year 2025 ...

Agilent Technologies Inc. (NYSE: A) today announced that the University of California has received an Agilent Research ...

Disputes arise over GST classification of spent catalysts and e-way bill rules. Learn how enforcement actions are impacting industry ...

Catalyst (CPRX) delivered earnings and revenue surprises of +33.33% and +8.77%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

CORAL GABLES, Fla. (AP) — CORAL GABLES, Fla. (AP) — Catalyst Pharmaceutical Partners Inc. (CPRX) on Wednesday reported third-quarter profit of $52.8 million. On a per-share basis, the Coral Gables, ...

Reported Q3 2025 Total Revenues of $148.4Million, Driven by Continued FIRDAPSE® Growth, Strong AGAMREE® Uptake and Growth, and Continued Demand ...

Immunocore's pipeline could offer long-term value beyond tebentafusp sales. See why I believe IMCR stock could qualify as a ...

A man from Springfield was arrested on Friday after police said he fled from officers while they were investigating him for narcotics offenses.

The deal, which includes Eli Lilly and Novo Nordisk, will slash prices for Medicare and Medicaid programme recipients.